Clinical Benefit of Circulating Tumor DNA Analysis in Early-Stage Breast Cancer

JAMA Oncol. 2020 Mar 1;6(3):439. doi: 10.1001/jamaoncol.2019.5677.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers, Tumor
  • Breast Neoplasms*
  • Circulating Tumor DNA*
  • Humans
  • Neoplasm Recurrence, Local

Substances

  • Biomarkers, Tumor
  • Circulating Tumor DNA